Human Bone Marrow CD36+ Early Erythroid Progenitor Cells
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Bone Marrow-CD36+ Early Erythroid Progenitor cells are derived fromBone Marrow-CD34+ cells in culture. The Bone Marrow-CD34+ cells are cultured for 7 to 8 days using a serum free expansion media for hematopoietic cells, with the addition of SCF (50ng/ml), EPO (2U/ml), IL-3 (10ng/ml), and IL-6 (10ng/ml) growth factors. The cells are harvested from culture, and the Bone Marrow-CD36+ cells are positively isolated, using direct immunomagnetic CD36 MicroBeads labeling system
Species | Human |
Cat.No | ABC-TC3118 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Progenitor Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Bone Marrow |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Immune Cells |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only